Eli Lilly cuts Zepbound price to widen access for obesity drug

Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for weight-loss therapies... ...